KLAC
45
3
HCP
54
2
EQR
33
6
D
32
10
APH
53
3
IR
46
3
CME
59
3
WHR
61
3
V
70
14
AZO
46
3
DNB
72
4
MHK
25
5
NWL
48
4
ROST
60
3
BEN
36
4
CAG
34
3
GE
60
5
WMT
68
-2
MA
60
5
WAT
55
11
KLAC
45
3
HCP
54
2
EQR
33
6
D
32
10
APH
53
3
IR
46
3
CME
59
3
WHR
61
3
V
70
14
AZO
46
3
DNB
72
4
MHK
25
5
NWL
48
4
ROST
60
3
BEN
36
4
CAG
34
3
GE
60
5
WMT
68
-2
MA
60
5
WAT
55
11
Financhill
Back

Skye Bioscience Quote, Financials, Valuation and Earnings

These 7 Stocks Will Be Magnificent in 2025

Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.
Sell
12

SKYE
Skye Bioscience

Last Price:
$2.70
Seasonality Move:
59.61%

7 Day Trial

ALL ACCESS PASS

$ 7

2025 Gold Forecast: A Perfect Storm for Demand

Discover our Gold Price Outlook for 2025--FREE--here

Skye Bioscience Price Quote

$2.70
-0.02 (-5.59%)
(Updated: December 21, 2024 at 5:47 AM ET)

Skye Bioscience Key Stats

Sell
12
Skye Bioscience (SKYE) is a Sell
Day range:
$2.66 - $3.09
52-week range:
$2.25 - $19.41
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
276.12
P/B ratio:
1.09%
Volume:
484.7K
Avg. volume:
187.4K
1-year change:
-10.82%
Market cap:
$82.5M
Revenue:
$0
EPS:
$-0.84

How Much Does Skye Bioscience Make?

Data Unavailable

Is Skye Bioscience Growing As A Company?

Data Unavailable

Skye Bioscience Stock Price Performance

  • Did Skye Bioscience Stock Go Up Last Month?
    Skye Bioscience share price went down by -36.45% last month
  • Did SKYE's Share Price Rise Over The Last Year?
    SKYE share price fell by -10.82% over the past 1 year

What Is Skye Bioscience 52-Week High & Low?

Skye Bioscience Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Skye Bioscience?

Data Unavailable

Is Skye Bioscience Cash Flow Positive?

Data Unavailable

Skye Bioscience Return On Invested Capital

Data Unavailable

Skye Bioscience Earnings Date & Stock Price

Skye Bioscience Competitors

  • Who Are Skye Bioscience's Competitors?
    Below is a list of companies who compete with Skye Bioscience or are related in some way:
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Oramed Pharmaceuticals Inc (ORMP)
    • Palatin Technologies Inc (PTN)
    • Viking Therapeutics Inc (VKTX)

Skye Bioscience Dividend Yield

Data Unavailable

Skye Bioscience Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 59.08%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable